Pacifying pain: mouse study reveals a gene-therapy approach could be used to relieve chronic pain

Written by Heather Jones, Future Science Group

Researchers at Navega Therapeutics (CA, USA) have revealed that CRISPR, a gene-editing technique, could potentially be used to treat individuals with chronic pain. This follows a study applying the novel technique on mice administered with chemotherapy, known to commonly cause pain in cancer patients. Should the method be translated to humans and the treatment demonstrated to be safe, it could potentially provide an alternative to opioids.  Physical pain is a problem we are all familiar with. Though it is generally manageable, it can be significantly debilitating for individuals with chronic, agonizing pain. Current medications have several drawbacks and despite decades...

To view the full article, please register now for access

It's completely free